CardioExchange Archive

September 4th, 2013

New Dual Biomarker Test Could Speed Rule-Out of MI in the ED

Larry Husten, PHD

A new study suggests that patients with suspected ACS and negative troponin and copeptin results at admission can safely be discharged if the clinical assessment is consistent with that decision.

---

September 3rd, 2013

Speedy Tour de France Racers Slower to Die

Larry Husten, PHD

For more of our ESC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. In recent years, concerns have been raised about possible adverse cardiovascular effects of intense endurance exercise. Additional concerns have been […]

---

September 3rd, 2013

Study Fails to Support Broader Patient Population for Cardiac-Resynchronization Therapy

Larry Husten, PHD

A new study from the Echo-CRT study group shows that CRT is not beneficial in patients with HF and a narrow QRS complex and may even be harmful.

---

September 2nd, 2013

Losartan Reduces Aortic Enlargement in Marfan Syndrome

Larry Husten, PHD

The COMPARE study provides the first confirmation that the angiotensin receptor blocker losartan reduces aortic enlargement in Marfan syndrome.

---

September 2nd, 2013

Automatic Wireless Monitoring Shows Benefits in Chronic Heart Failure

Larry Husten, PHD

The In-Time trial is the first to show that home monitoring of HF patients may be beneficial.

---

September 2nd, 2013

Cardiovascular Outcome Studies in Diabetes Drugs Finally Arrive

Larry Husten, PHD

Large trials of two diabetes drugs show that they appear to be safe, but do not improve CV outcomes.

---

September 1st, 2013

Pretreatment with Prasugrel Not Indicated in NSTEMI

Larry Husten, PHD

Pretreatment prasugrel for NSTEMI was not effective in the ACCOAST trial.

---

September 1st, 2013

Positive Results for Edoxaban in VTE/PE

Larry Husten, PHD

Findings from the Hokusai-VTE trial of edoxaban

---

September 1st, 2013

A Disruptive TASTE of the Future?

Larry Husten, PHD

Negative findings from a registry-based randomized trial of pre-PCI thrombus aspiration for STEMI patients

---

September 1st, 2013

Disappointing Results with Dabigatran for Mechanical Valves

Larry Husten, PHD

For more of our ESC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. Despite being more durable than bioprosthetic valves, mechanical heart valves are often not chosen because of the requirement for lifelong […]

---